Accelerator adds clinical research giant to investor mix |
Connect with TechFlash on our Facebook page for all the latest technology news headlines and commentary, plus information and access to special events, photos from events, promotions and more.
Accelerator Corp., the Seattle biotechnology incubator, is taking a new investor into its syndicate, one that could help it cut developments costs and stretch its resources.
The new investor is Pharmaceutical Product Development Inc. (PPD), one of the world’s largest contract research organizations. PPD’s investment will give Accelerator a bigger kitty to seed startup companies. But beyond that, the Wilmington, N.C.-based company, which conducts clinical trials for drug and medical device firms around the world, can draw on its vast resources to help Accelerator assess early-stage biotech concepts and their potential path to market.
With the economy in turmoil and the biotech sector as a whole taking big hits, that kind of arrangement could help Accelerator stretch its resources and weed out technologies that won’t fly in the clinic.
“Clinical work is so incredibly expensive, and if you make the wrong choices, it can be an incredible setback,” said David Schubert, Accelerator’s chief business officer. PPD can help Accelerator “make the right choices in the very complicated world of clinical trials and the FDA and trying to limit surprises,” he added.
Accelerator Corp., founded in 2003, is a syndicate of investors that forms early-stage biotech companies and provides them with office space, management and scientific guidance in exchange for an equity stake. The goal is for startups to eventually attract outside investors and “graduate” from the Accelerator campus in Seattle’s South Lake Union.
Accelerator didn’t specify the size of PPD’s investment, but it appears to be in the range of $4.5 million. The fund, with PPD’s investment, now stands at $27 million; when the fund was first announced in August 2007, it totaled $22.5 million.
PPD joins Accelerator’s existing investor group of Amgen Ventures, Arch Venture Partners, OVP Venture Partners, WRF Capital, and Alexandria Real Estate Equities Inc. The incubator is affiliated with the Institute for Systems Biology, the Seattle nonprofit research center headed by genomics pioneer Leroy Hood.
Publicly traded PPD Inc., with 10,000 staff and offices in 33 countries, has a market capitalization of nearly $3 billion and ranks among the biggest contract research organizations in the world.
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
Who's creating today's energy efficient buildings? Find out at the BetterBricks Awards, Feb. 16
BetterBricks Awards salute the individuals leading the way for high performance commercial buildings with an emphasis on energy efficiency. Join us as we recognize these standout green building professionals.
Award categories include: Advocate; Architect/Designer; Facility Manager/Operator; and Owner/Developer.
Keynote Speaker: Kevin Kampschroer, Director of U.S. GSA's Office of Federal High Performance Buildings. Kevin leads the U.S. General Services Administration's efforts in building sustainability and accelerating industry adoption of sustainable principles across all aspects of a building's life.
Register here by February 10!
If you are interested in buying a table, email Monica Alquist or call her at 206-876-5404.
The Triple Door Presents: The Atomic Bombshells "J'ADORE!: A Burlesque Valentine"
Seattle's reigning Burlesque super-troupe delivers a gorgeous and glittering VALENTINE featuring some of the Bombshells' most exhilarating acts to date. J'Adore! promises to celebrate l'amour with good humor, style, and a healthy dose of dazzle! Bring a friend, a lover, a family member, or a secret crush, and celebrate with the Valentine's Burlesque spectacular that will leave you shouting: "J'ADORE......The Atomic Bombshells!" The incomparable Jasper McCann emcees with high style and charm.
Please visit www.thetripledoor.net for a full schedule of future performances.
The Triple Door Presents: Bob Mould – See A Little Light: An Evening of Reading and Music
"Bob Mould. Those two words are synonymous with integrity. From Husker Du in the last century to right at this moment, Bob is the real deal, writing and playing music for music's sake. He's a great songwriter and performer. I have been a fan of Bob's for thirty years now with no end in sight." -Henry Rollins
Please visit www.thetripledoor.net for a full schedule of future performances.
Why Choose BDO for your SOC (previously SAS 70) Reports?
BDO’s experience in providing attestation services (SAS 70/SSAE 16, AT 101, AT 201, AT 601, etc.) to a broad range of industries, and our team of skilled professionals distinctly qualifies us to serve as your company’s Service Auditor. By leveraging the BDO global network of control specialists, we are poised to provide global services in more than 1,000 offices and across 119 countries. Many organizations find that investing in reports on controls may result in benefits, including:
• Increased client confidence
• Improved competitive advantage
• Minimization of frequent audits
• Streamlined business processes and controls
• Enhanced risk management
For detailed information contact Paul Martini at pmartini@bdo.com.